Dupont Jakob

Director at PYXS; EVP, Head of R&D at ATRA; Chief Medical Officer at GOSS, and 1 more

Sold, on record
$2.2M
Dollars the filings state
Form 4 sales
29
Latest Jun 30, 2026
Form 144 notices
0
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ATRAPlan not stated
    Jan 3 2022

    Sold 5,000 shares at $16.01 ($80k)

    Dupont Jakob, EVP, Head of R&D

    Sold 5.2% of holdings ($1.5M position)90,594 shares left1x usual sizeFiling

  2. 2 Form 4 sale ATRAPlan not stated
    Feb 10 +38 days

    Sold 5,000 shares at $16.00 ($80k)

    Dupont Jakob, EVP, Head of R&D

    Sold 5.2% of holdings ($1.5M position)90,594 shares left1x usual sizeFiling

  3. 3 Form 4 sale ATRAPlan not stated
    Mar 1 +19 days

    Sold 2,221 shares at $9.86 ($22k)

    Dupont Jakob, EVP, Head of R&D

    Sold 1.3% of holdings ($1.7M position)166,879 shares left0.4x usual sizeFiling

  4. 4 Form 4 sale ATRAPlan not stated
    May 17 +77 days

    Sold 3,873 shares at $5.32 ($21k)

    Dupont Jakob, EVP, Head of R&D

    Sold 2.3% of holdings ($888k position)163,006 shares left0.8x usual sizeFiling

  5. 5 Form 4 sale ATRAPlan not stated
    Aug 16 +91 days

    Sold 4,124 shares at $5.03 ($21k)

    Dupont Jakob, EVP, Head of R&D

    Sold 2.5% of holdings ($820k position)158,882 shares left0.8x usual sizeFiling

  6. 6 Form 4 sale ATRAPlan not stated
    Nov 16 +92 days

    Sold 4,342 shares at $4.49 ($19k)

    Dupont Jakob, EVP, Head of R&D

    Sold 2.7% of holdings ($713k position)154,540 shares left1x usual sizeFiling

  7. 7 Form 4 sale ATRAPlan not stated
    Mar 2 +106 days

    Sold 5,074 shares at $3.63 ($18k)

    Dupont Jakob, EVP, Head of R&D

    Sold 1.7% of holdings ($1.1M position)290,794 shares left1.2x usual sizeFiling

  8. 8 Form 4 sale PYXSRoutine
    Jun 30 +1216 days

    Sold 35,000 shares at $3.06 ($107k)

    Dupont Jakob, Director

    10b5-1 planSold 47.5% of holdings ($226k position)38,741 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (29)

Form 144 notices and Form 4 sales by Dupont Jakob
Source
Jun 30, 2026PYXSDirectorForm 4 sale35,000$107k47.5%RoutineSEC
Mar 2, 2023ATRAEVP, Head of R&DForm 4 sale5,074$18k1.7%Plan not statedSEC
Nov 16, 2022ATRAEVP, Head of R&DForm 4 sale4,342$19k2.7%Plan not statedSEC
Aug 16, 2022ATRAEVP, Head of R&DForm 4 sale4,124$21k2.5%Plan not statedSEC
May 17, 2022ATRAEVP, Head of R&DForm 4 sale3,873$21k2.3%Plan not statedSEC
Mar 1, 2022ATRAEVP, Head of R&DForm 4 sale2,221$22k1.3%Plan not statedSEC
Feb 10, 2022ATRAEVP, Head of R&DForm 4 sale5,000$80k5.2%Plan not statedSEC
Jan 3, 2022ATRAEVP, Head of R&DForm 4 sale5,000$80k5.2%Plan not statedSEC
Dec 1, 2021ATRAEVP, Head of R&DForm 4 sale5,000$90k5.2%Plan not statedSEC
Nov 16, 2021ATRAEVP, Head of R&DForm 4 sale2,199$38k2.4%Plan not statedSEC
Nov 2, 2021ATRAEVP, Head of R&DForm 4 sale5,000$82k5.1%Plan not statedSEC
Aug 17, 2021ATRAEVP, Head of R&DForm 4 sale2,152$27k2.3%Plan not statedSEC
May 18, 2021ATRAEVP, Head of R&DForm 4 sale5,184$75k5.2%Plan not statedSEC
Dec 30, 2019GOSSChief Medical OfficerForm 4 sale41,994$632k100.0%UnusualSEC
Jan 11, 2016OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale2,500$50k10.8%Plan not statedSEC
Jan 7, 2016OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale2,162$48k9.5%Plan not statedSEC
Dec 10, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale2,500$51k9.9%Plan not statedSEC
Nov 10, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale2,500$53k9.9%Plan not statedSEC
Oct 26, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale5,000$100k18.0%UnusualSEC
Aug 10, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale2,500$56k10.0%Plan not statedSEC
Jul 10, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale2,500$50k10.0%Plan not statedSEC
Jul 6, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale2,500$53k10.0%Plan not statedSEC
Apr 10, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale1,500$40k6.3%Plan not statedSEC
Mar 10, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale1,500$41k6.5%Plan not statedSEC
Feb 10, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale1,500$36k6.5%Plan not statedSEC
Jan 12, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale1,500$39k6.5%Plan not statedSEC
Jan 5, 2015OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale7,500$173k25.8%UnusualSEC
Jul 23, 2014OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale1,500$35k6.7%Plan not statedSEC
Jun 26, 2014OncoMed Pharmaceuticals IncSVP & Chief Medical OfficerForm 4 sale1,500$35k6.7%Plan not statedSEC